Navneet Puri

Dr. Puri is a pharmacist by education with over 22 years of healthcare industry experience.

He founded Nevakar in 2015 with a vision of improving patients’ quality of life and healthcare outcomes in hospital and ophthalmology segments.

Prior to Nevakar, Dr Puri spent several years in product development and drug delivery of parenteral pharmaceuticals at Baxter Healthcare Corp. and Amgen Inc. He founded InnoPharma, Inc. in 2005, focusing on development of complex generic injectable dosage formulations. Following the acquisition of InnoPharma by Pfizer in 2014, he stayed on as Vice President of Pfizer’s Worldwide Research & Development until 2015.

Dr. Puri received Future 50 magazine’s Smart CEO award in 2015. He was also awarded the EY Entrepreneur of The Year award from the state of NJ in 2015.

Dr Puri’s past board positions include InnoPharma, Eyenuk and Xeris Pharmaceuticals. His current board positions include Nevakar, Alzeca Biosciences, BioNJ and [Chair] Rutgers Biomedical and Health Sciences Leadership Council. Dr. Puri earned a MS from the University of Mississippi and a PhD in Pharmaceutics from Rutgers University.